Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesEBIATMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Fennec Pharmaceuticals (FENC) Long-Term Debt Issuances (2022)

Fennec Pharmaceuticals' Long-Term Debt Issuances history spans 4 years, with the latest figure at -$65000.0 for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to -$65000.0, compared with a TTM value of $19.9 million through Dec 2022, changed N/A, and an annual FY2023 reading of $5.0 million, down 79.96% over the prior year.
  • Long-Term Debt Issuances for Q4 2022 was -$65000.0 at Fennec Pharmaceuticals, down from $20.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $20.0 million in Q3 2022, with the low at -$65000.0 in Q4 2022.